0001354457-16-000508.txt : 20160926
0001354457-16-000508.hdr.sgml : 20160926
20160926093330
ACCESSION NUMBER: 0001354457-16-000508
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20160926
DATE AS OF CHANGE: 20160926
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: EPIRUS Biopharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001135906
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043514457
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51171
BUSINESS ADDRESS:
STREET 1: 699 BOYLSTON ST
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 600-3497
MAIL ADDRESS:
STREET 1: 699 BOYLSTON ST
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Zalicus Inc.
DATE OF NAME CHANGE: 20100908
FORMER COMPANY:
FORMER CONFORMED NAME: COMBINATORX, INC
DATE OF NAME CHANGE: 20041208
FORMER COMPANY:
FORMER CONFORMED NAME: COMBINATORX INC
DATE OF NAME CHANGE: 20010301
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0001135906
EPIRUS Biopharmaceuticals, Inc.
000-51171
650 Albany Street, Sixteenth Floor
Boston
MA
MASSACHUSETTS
02118
617 425-7000
Common Stock
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2016-09-26
EX-99.25
2
eprsdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
September 26, 2016, EPIRUS Biopharmaceuticals, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove from
listing the common stock of EPIRUS Biopharmaceuticals, Inc.
(the Company), effective at the opening of the trading
session on October 6, 2016. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was
notified of the Staffs determination on July 26, 2016.
The Company did not appeal the Staff determination to the
Hearings Panel, and the Staff determination to delist the
Company became final on August 4, 2016.